Ensign Peak Advisors’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Buy
12,222
+50
+0.4% +$1.08K ﹤0.01% 1110
2026
Q1
$140K Hold
12,172
﹤0.01% 1478
2025
Q4
$175K Sell
12,172
-21,900
-64% -$379K ﹤0.01% 1370
2025
Q3
$645K Sell
34,072
-8,950
-21% -$147K ﹤0.01% 1263
2025
Q2
$922K Hold
43,022
﹤0.01% 1288
2025
Q1
$564K Hold
43,022
﹤0.01% 1518
2024
Q4
$578K Buy
43,022
+4,100
+11% +$66K ﹤0.01% 1556
2024
Q3
$826K Hold
38,922
﹤0.01% 1431
2024
Q2
$616K Hold
38,922
﹤0.01% 1538
2024
Q1
$579K Buy
+38,922
New +$533K ﹤0.01% 1588
2022
Q4
Sell
-21,460
Closed -$107K 2089
2022
Q3
$107K Hold
21,460
﹤0.01% 2075
2022
Q2
$91K Hold
21,460
﹤0.01% 1979
2022
Q1
$214K Hold
21,460
﹤0.01% 1863
2021
Q4
$168K Buy
+21,460
New +$269K ﹤0.01% 1966

Other funds holding OSCR

Ensign Peak Advisors's OSCR Position: Q2 2026 in Review

Ensign Peak Advisors increased its Oscar Health (OSCR) stake by 0.41% in Q2 2026, buying an estimated $1.08K and bringing the position to 12,222 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #1110.

Ensign Peak Advisors first reported a position in OSCR in Q4 2021 and has held it in 14 quarters since. The position peaked at $922K in Q2 2025. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Ensign Peak Advisors held 12,222 shares of Oscar Health worth $349K as of Q2 2026.
  • Ensign Peak Advisors bought 50 Oscar Health shares in Q2 2026, an estimated $1.08K.
  • Oscar Health made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1110 holding.
  • Ensign Peak Advisors first reported a position in Oscar Health in Q4 2021 and has held it in 14 quarters since.
  • Ensign Peak Advisors's Oscar Health position peaked at $922K in Q2 2025.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.